文献速递免疫规划传染病防控与疫情报告

密码子及密码子对去优化构建的EV-A71疫苗候选株可抵御小鼠致死性攻击

Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
PubMed 文献 · Vaccine · 2021-02-25

所有毒株均可存活且复制动力学相似,但空斑大小与去优化程度成反比。6周龄ICR小鼠腹腔免疫CD X和CPD X候选株后产生高滴度IgG和强中和抗体,子代在致死性攻击中完全保护;CD X和CPD X是有前景的EV-A71减毒活疫苗候选株。

要点

  • CD X和CPD X候选株可诱导高滴度抗EV-A71 IgG和强中和抗体。
  • 免疫CD X或CPD X的母鼠子代在致死性攻击中获完全保护。
  • CD XY和CPD XY候选株免疫后保护不完全,攻击后出现延迟症状并死亡。

核心结论

  • CD X和CPD X去优化疫苗候选株能诱导良好的中和抗体并赋予免疫保护,是有前景的EV-A71减毒活疫苗候选株。

研究设计与样本

  • 6周龄ICR小鼠腹腔免疫选定的CD和CPD X及XY候选株(分别覆盖VP2-VP3和VP2-VP3-VP1基因)。
  • 1日龄乳鼠主动免疫CD X、CPD X、CD XY和CPD XY候选株后进行致死性攻击。

主要发现

  • 去优化病毒在体外生长减弱,48小时病毒蛋白表达降低,39℃时病毒RNA更低。
  • 所有候选疫苗均诱导与野生型EV-A71相似的高水平抗EV-A71 IgG。
  • CD X和CPD X疫苗产生强中和抗体,而CD XY和CPD XY未产生。
  • 致死性攻击后,WT、CD X和CPD X免疫小鼠的子代完全保护,CD XY和CPD XY免疫小鼠出现延迟症状并最终死亡。

临床怎么用

  • CD X和CPD X可作为EV-A71减毒活疫苗的优先候选株推进后续开发。
  • 免疫原性评价需关注中和抗体滴度,仅IgG水平不能预测保护效果。

局限性

  • 研究仅在小鼠模型中进行,尚未在人体评估安全性和免疫原性。
  • CPD XY候选株在乳鼠主动免疫中仅提供40%保护,提示部分去优化组合保护效果不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Enterovirus A71 (EV-A71) causes hand, foot and mouth disease (HFMD) in young children. It is associated with severe neurological complications and death. This study aims to develop a live-attenuated vaccine by codon deoptimization (CD) and codon-pair deoptimization (CPD) of EV-A71. CD is generated by introducing the least preferred codons for amino acids while CPD increases the presence of underrepresented codon pairs in the specific genes. CD and CPD chimeras were generated by synonymous mutations at the VP2, VP3, VP1 and 2A gene regions, designated as XYZ. All twelve deoptimized viruses were viable with similar replication kinetics, but the plaque sizes were inversely proportional to the level of deoptimization. All the deoptimized viruses showed attenuated growth in vitro with reduced viral protein expression at 48 h and lower viral RNA at 39 °C. Six-week-old ICR mice were immunized intraperitoneally with selected CD and CPD X and XY vaccine candidates covering the VP2-VP3 and VP2-VP3-VP1 genes, respectively. All vaccine candidates elicited high anti-EV-A71 IgG levels similar to wild-type (WT) EV-A71. The CD X and CPD X vaccines produced robust neutralizing antibodies but not the CD XY and CPD XY. On lethal challenge, offspring of mice immunized with WT, CD X and CPD X were fully protected, but the CD XY- and CPD XY-vaccinated mice had delayed symptoms and eventually died. Similarly, active immunization of 1-day-old suckling mice with CD X, CPD X and CD XY vaccine candidates provided complete immune protection but CPD XY only protected 40% of the challenged mice. Histology of the muscles from CD X- and CPD X-vaccinated mice showed minimal pathology compared to extensive inflammation in the post-challenged mock-vaccinated mice. Overall, we demonstrated that the CD X and CPD X elicited good neutralizing antibodies, conferred immune protection and are promising live-attenuated vaccine candidates for EV-A71.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lee MHP, Tan CW, Tee HK, et al. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice. Vaccine. 2021. PMID: 33640144. doi:10.1016/j.vaccine.2021.02.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。